February 23, 2017: Speculation on what company will make a bid for beleaguered BMS has ramped up since billionaire activist investor Carl Icahn acquired an undisclosed number of shares based on takeover rumors.
February 23, 2017: If there’s one reason to view biotech as the new center for the tech industry boom, it may be the number of 20-somethings founding biotech startups.
February 23, 2017: Roche reported a death in its ACE910 study of emicizumab in patients with hemophilia A and factor VIII inhibitors. The information was released by the European Hemophilia Consortium.
February 23, 2017: Harvard chemical biologist Greg Verdine has an impressive resume. In addition to his academic pedigree, Verdine co-founded eight startups and two non-profit institutions.